Flying The Web For News.
  • 2024 Presidential Election
    2024 Presidential Election
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Gain Therapeutics Announces Pricing of $11.0 Million Public Offering

Details
Category: Globe NewsWire News Distribution Service

BETHESDA, Md., June 13, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the pricing of an underwritten public offering of (i) 7,116,547 shares of its common stock at a public offering price of $1.35 per share and (ii) pre-funded warrants to purchase 1,031,602 shares of common stock in lieu…


Posted: 2024-06-14 01:00:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Tags

press | release | gain | therapeutics | announces


Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Gain Therapeutics Announces Pricing of $11.0 Million Public Offering - Newscast

Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

Thu, 14 Nov 2024 13:30:00 GMT Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Syncona launches new portfolio company Slingshot, the Syncona Accelerator

Thu, 14 Nov 2024 03:24:00 GMT Syncona Ltd, (“Syncona”) a leading life science investor focused on creating, building and scaling global leaders in life science, today announces that it has launched a new portfolio company ...

Gain Therapeutics Inc (GANX)

Wed, 23 Oct 2024 12:59:00 GMT ByInvesting.com • Aug 29, 2024 Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s ...

Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial

Tue, 22 Oct 2024 23:05:00 GMT MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare ... Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the Private ...

Coya Therapeutics Announces $10.0 Million Private Placement

Tue, 22 Oct 2024 06:00:00 GMT This press release does not constitute an offer to ... securities laws of any such state or other jurisdiction. About Coya Therapeutics, Inc. Headquartered in Houston, TX, Coya Therapeutics ...


Blow Us A Whistle